Blood–brain barrier in brain tumors: biology and clinical relevance

F Mo, A Pellerino, R Soffietti, R Rudà - International journal of molecular …, 2021 - mdpi.com
The presence of barriers, such as the blood–brain barrier (BBB) and brain–tumor barrier
(BTB), limits the penetration of antineoplastic drugs into the brain, resulting in poor response …

Amino acids, peptides, and proteins: implications for nanotechnological applications in biosensing and drug/gene delivery

S Er, U Laraib, R Arshad, S Sargazi, A Rahdar… - Nanomaterials, 2021 - mdpi.com
Over various scientific fields in biochemistry, amino acids have been highlighted in research
works. Protein, peptide-and amino acid-based drug delivery systems have proficiently …

Deep penetrating and sensitive targeted magnetic particle imaging and photothermal therapy of early‐stage glioblastoma based on a biomimetic nanoplatform

X Huang, H Hui, W Shang, P Gao, Y Zhou… - Advanced …, 2023 - Wiley Online Library
Early diagnosis can effectively improve the survival of glioblastoma multiforme (GBM). A
specific imaging technique that is simultaneously deep penetrating and sensitive to small …

A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment

Y Xing, F Yasinjan, M Yang, Y Du, H Geng, M He… - Nano Today, 2023 - Elsevier
In recent years, nano-based drug delivery systems have gradually been regarded as a
promising approach to improve the current glioblastoma treatment, attracting many …

Molecular targeted therapy: a new avenue in glioblastoma treatment

O El Atat, R Naser, M Abdelkhalek… - Oncology …, 2022 - spandidos-publications.com
Glioblastoma, also referred to as glioblastoma multiforme (GBM), is grade IV astrocytoma
characterized by being fast-growing and the most aggressive brain tumor. In adults, it is the …

Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma

Y Li, Y Wang, L Gao, Y Tan, J Cai, Z Ye… - Journal of …, 2022 - Springer
Background Glioblastoma (GBM) is the most common and fatal primary tumor in the central
nervous system (CNS). Due to the existence of blood–brain barrier (BBB), most therapeutics …

[HTML][HTML] MicroRNA-based therapy for glioblastoma: Opportunities and challenges

Q Lei, Y Yang, W Zhou, W Liu, Y Li, N Qi, Q Li… - European Journal of …, 2023 - Elsevier
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor and
is characterized by high mortality and morbidity rates and unpredictable clinical behavior …

Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors

X Yang, M Gao, R Xu, Y Tao, W Luo, B Wang… - Frontiers in …, 2022 - frontiersin.org
According to the difference in temperature, thermotherapy can be divided into thermal
ablation and mild hyperthermia. The main advantage of thermal ablation is that it can …

Gene therapy for high grade glioma: the clinical experience

ML Varela, A Comba, SM Faisal, A Argento… - Expert opinion on …, 2023 - Taylor & Francis
Introduction High-grade gliomas (HGG) are the most common malignant primary brain
tumors in adults, with a median survival of~ 18 months. The standard of care (SOC) is …

Bibliometric analysis of research on immunogenic cell death in cancer

Y Zhou, F Hu, Y Cui, H Wu, S Hu, W Wei - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Immunotherapy is changing the way we treat cancer. Immunogenic cell death
(ICD) has received considerable attention in the treatments of various cancer types, due to …